• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Romo Tammy converted options into 1,551 shares and returned $75,018 worth of shares to the company (465 units at $161.33), increasing direct ownership by 2% to 62,366 units (SEC Form 4)

    5/27/25 8:00:14 PM ET
    $THC
    Hospital/Nursing Management
    Health Care
    Get the next $THC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Romo Tammy

    (Last) (First) (Middle)
    14201 DALLAS PARKWAY

    (Street)
    DALLAS TX 75254

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    TENET HEALTHCARE CORP [ THC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/23/2025 M 1,551 A (1) 62,831 D
    Common Stock 05/23/2025 D 465 D $161.33 62,366 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (2) 05/22/2025 A 1,333 05/22/2026 05/22/2026 Common Stock 1,333 $0 1,333 D
    Restricted Stock Units (1) 05/23/2025 M 1,551 05/23/2025 05/23/2025 Common Stock 1,551 (1) 0 D
    Explanation of Responses:
    1. Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 30% of her restricted stock units for cash and 70% for shares of THC common stock.
    2. Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.
    Chad J. Wiener, as Attorney-in-fact for Tammy Romo 05/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $THC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $THC

    DatePrice TargetRatingAnalyst
    5/29/2025$195.00Equal Weight → Overweight
    Wells Fargo
    4/15/2025$137.00Outperform → Neutral
    Robert W. Baird
    3/26/2025$165.00Overweight
    Morgan Stanley
    2/26/2025$175.00Buy
    TD Cowen
    12/17/2024$175.00Overweight
    Analyst
    12/16/2024$196.00 → $140.00Buy → Neutral
    Goldman
    11/25/2024$205.00 → $150.00Overweight → Equal Weight
    Wells Fargo
    11/22/2024$195.00Strong Buy → Outperform
    Raymond James
    More analyst ratings

    $THC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Tenet Healthcare upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Tenet Healthcare from Equal Weight to Overweight and set a new price target of $195.00

      5/29/25 8:14:10 AM ET
      $THC
      Hospital/Nursing Management
      Health Care
    • Tenet Healthcare downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Tenet Healthcare from Outperform to Neutral and set a new price target of $137.00

      4/15/25 9:28:30 AM ET
      $THC
      Hospital/Nursing Management
      Health Care
    • Morgan Stanley initiated coverage on Tenet Healthcare with a new price target

      Morgan Stanley initiated coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $165.00

      3/26/25 7:51:37 AM ET
      $THC
      Hospital/Nursing Management
      Health Care

    $THC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tenet to Participate in BofA Securities 2025 Health Care Conference

      Tenet Healthcare Corporation (NYSE:THC) is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, beginning at 1:40 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals.

      5/9/25 4:00:00 PM ET
      $THC
      Hospital/Nursing Management
      Health Care
    • Tenet Reports Strong First Quarter 2025 Results

      Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share Adjusted diluted earnings per share1 increased 35.4% to $4.36 in first quarter 2025 compared to $3.22 in first quarter 2024 Consolidated Adjusted EBITDA1 in first quarter 2025 increased 13.6% to $1.163 billion compared to first quarter 2024; First quarter 2025 Adjusted EBITDA margin was 22.3% First quarter 2025 Ambulatory Care Adjusted EBITDA of $456 million increased 15.7% over first quarter 2024 FY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion Tenet Healthcare Corporation (Tenet) (NYSE:THC) today announced its results f

      4/29/25 6:45:00 AM ET
      $THC
      Hospital/Nursing Management
      Health Care
    • Tenet to Report Its First Quarter 2025 Results on April 29th

      Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We als

      4/9/25 9:00:00 AM ET
      $THC
      Hospital/Nursing Management
      Health Care